Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Neuronetics and Jorey Chernett Announce Shared Vision
-
Arctic Wolf's Aurora Agentic SOC Sets a New Standard for Scale, Value, Trust, and Speed in the Age of AI
-
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH
-
GSI Technology to Participate in Needham Virtual Semiconductor & SemiCap Conference on August 19, 2026
-
King Street Property Group Offers Cash Home Buying With 7-Day Closings in Washington D.C.
-
Miggo’s Emerging Threat and AI/ML Partner Rulesets Now Available Directly Within AWS WAF
-
1st Care Home Brings Compassionate, Personalized Adult Family Home Care to Battle Ground, Washington
-
Cohen & Company Reports Second Quarter 2026 Financial Results
-
Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases
-
VirTra Sets Second Quarter 2026 Conference Call for Thursday, August 13, 2026 at 4:30 p.m. ET
-
eGain Points to AI KnowledgeOps as Key to AI Governance at Ai4 2026
-
Buccaneers and Fifth Third Bank Elevate Pewter Partnership With Introduction of First-Ever Practice Jersey Patch
-
Shoals Technologies Group and TerraFlow Energy Forge Multi-Gigawatt Partnership to Advance the Future of Energy Storage
-
Schneider Electric releases pioneering study assessing arc flash risk in 800 VDC data centers aligning with world's leading hyperscalers
-
EagleNXT Names Head of Sales and Business Development for Counter-UAS
-
WaterPure International Executes Research License Agreement with NASA to Evaluate Advanced Water Filtration Technologies
-
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation
-
Cohen & Company Reports Second Quarter 2026 Financial Results
-
KellyOCG® Named Global and U.S. Leader in Everest Group’s 2026 RPO PEAK Matrix®
-
The Oncology Institute Rebrands as Starling Oncology
-
Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results
-
Swarmer and Oak Grove Technologies Announce Strategic Partnership to Advance Autonomous Drone Swarming Capabilities for U.S. Special Operations
-
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
-
Canon Medical Systems USA Announces Tsuneo "Neo" Imai as President and Chief Executive Officer
-
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
-
Atlas Air Worldwide Completes Strategic Investment in Air Atlanta
-
Blue Star Families Names Charles Plummer as Its First President
-
Kaléo Announces License Agreement with Amgen for Auto-Injector Technology
-
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
-
From AI Prompts to Perfect Property Placement: Phillips Edison & Company Makes Site Selection Smarter
-
Powerus Awarded U.S. Air Force IDIQ Contract Up to $90 Million for Aerial Denial
-
Freedom Metals Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 4, 2026
-
Amogy and 2G Energy Successfully Demonstrate Integrated Ammonia-to-Power Generation with Natural Gas Multi-Fuel Capability
-
Aspida Life and Market Synergy Group Launch T. Rowe Price U.S. Equity 15 Index in Synergy Choice™ FIA Suite
-
Sweed Launches AI-Powered Smart Surveys With Google Review Capabilities for Cannabis Dispensaries
-
The best-selling Enduro motorcycle in the world is now electric, Stark is EBIT-Positive as First-Half-Year Revenues grow 46% to €86 Million
-
ASML reports transactions under its current share buyback program
-
Transaction in Own Shares
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.09 Per Share for August 2026
-
Nexera Enters into Letter of Intent for Exclusive Distribution Rights to Darknet Intelligence Platform for Data Centers
-
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
-
Tyson Foods Third Quarter 2026 Financial Results Available on the Company’s Investor Relations Website
-
Curium Announces Definitive Agreement to Merge with Lantheus
-
Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform
-
SOLOWIN HOLDINGS’ (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin
-
Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)
-
HUB Security Regains Full Compliance with Nasdaq Listing Requirements
-
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
-
Crescent Biopharma Announces Grants of Inducement Awards
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
